JP3417085B2 - Method for producing fungicide inclusion compound - Google Patents

Method for producing fungicide inclusion compound

Info

Publication number
JP3417085B2
JP3417085B2 JP24874494A JP24874494A JP3417085B2 JP 3417085 B2 JP3417085 B2 JP 3417085B2 JP 24874494 A JP24874494 A JP 24874494A JP 24874494 A JP24874494 A JP 24874494A JP 3417085 B2 JP3417085 B2 JP 3417085B2
Authority
JP
Japan
Prior art keywords
compound
acid
inclusion compound
solution
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP24874494A
Other languages
Japanese (ja)
Other versions
JPH0892015A (en
Inventor
稔 八木
あや子 関川
和美 中根
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kurita Water Industries Ltd
Original Assignee
Kurita Water Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kurita Water Industries Ltd filed Critical Kurita Water Industries Ltd
Priority to JP24874494A priority Critical patent/JP3417085B2/en
Publication of JPH0892015A publication Critical patent/JPH0892015A/en
Application granted granted Critical
Publication of JP3417085B2 publication Critical patent/JP3417085B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】この発明は殺菌剤包接化合物の製
造方法に関し、特にその微小結晶を効率的に製造する方
法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a fungicide inclusion compound, and more particularly to a method for efficiently producing microcrystals thereof.

【0002】[0002]

【従来の技術】殺菌剤をゲスト化合物とした包接化合物
を工業的に製造する方法としては、一般に、包接化合物
の結晶を溶液中より析出させ、これを濾別・乾燥する方
法がとられている。このときに、包接化合物を溶液中よ
り析出させる方法としては、ホスト化合物をメタノール
等の有機溶媒に溶解した溶液を攪拌しながら、これに別
途ゲスト化合物を溶解した溶液を、少量ずつ注加して包
接化合物を析出させる方法が多くとられる。
2. Description of the Related Art As a method for industrially producing a clathrate compound using a fungicide as a guest compound, a method of precipitating crystals of the clathrate compound from a solution, filtering and drying it is generally employed. ing. At this time, as a method of precipitating the clathrate compound from the solution, while stirring the solution in which the host compound is dissolved in an organic solvent such as methanol, a solution in which a guest compound is separately added thereto is added little by little. There are many methods of precipitating an inclusion compound.

【0003】[0003]

【発明が解決しようとする課題】しかし、この方法に
は、従来、次のような問題点があった。 1)温度等の反応条件によっては、包接化合物が析出し
ないことがある。 2)包接化合物が析出しても、原料薬品のロットの違い
等によって、析出が始まる時期が変化す ることがあ
り、析出開始時期の正確な予測が難しい。 3)包接化合物が析出しても、結晶粒径が大きくなりす
ぎることがある。このために、目的とす る微小結晶の
収率が低下し、粗大結晶の粉砕が必要となることもあ
る。
However, this method has hitherto had the following problems. 1) Depending on the reaction conditions such as temperature, the clathrate compound may not be precipitated. 2) Even when the clathrate compound is deposited, the timing at which the deposition starts may change due to differences in the lots of raw material chemicals, etc., making it difficult to accurately predict the timing at which the deposition starts. 3) Even if the clathrate compound is deposited, the crystal grain size may become too large. For this reason, the yield of the desired fine crystals may be reduced, and it may be necessary to crush the coarse crystals.

【0004】以上の理由により、従来の技術では、目的
とする微小粒径の包接化合物を、高収率で、再現性よく
製造することが困難であった。
For the above reasons, it has been difficult with the prior art to produce the target inclusion compound having a minute particle size in a high yield and with good reproducibility.

【0005】[0005]

【課題を解決するための手段】本発明は、殺菌剤を包接
することができるホスト化合物を溶解した溶液に殺菌剤
を溶解した溶液を攪拌下注加して殺菌剤包接化合物を製
造する方法において、微小な殺菌剤包接化合物を高収率
で再現性良く製造する方法を提供する。本発明の方法に
おいては、上記殺菌剤溶液をホスト溶液に攪拌下注加す
る工程の途中で、ホスト化合物溶液に予め調整した殺菌
剤包接化合物の種結晶を混合溶液液に添加する。本発明
は、ホスト化合物をメタノール等の有機溶媒に溶解した
溶液に、これを攪拌しながら、別途殺菌剤ゲスト化合物
を溶解した溶液を少量ずつ注加して殺菌剤包接化合物を
析出させる殺菌剤包接化合物の製造方法において、微小
な殺菌剤包接化合物結晶を、高収率で、再現性よく、安
定して製造する方法を提供する。本発明の方法において
は、上記の殺菌剤ゲスト化合物を溶解した溶液を少量ず
つ注加する工程の途中で、予め調整した該包接化合物の
種結晶を添加する。
DISCLOSURE OF THE INVENTION The present invention provides a method for producing a fungicide inclusion compound by pouring a solution of a fungicide dissolved in a solution of a host compound capable of clathrating a fungicide under stirring. In, there is provided a method for producing a minute bactericide inclusion compound with high reproducibility and high yield. In the method of the present invention, seed crystals of the sterilizing agent inclusion compound prepared in advance in the host compound solution are added to the mixed solution solution during the step of pouring the sterilizing agent solution into the host solution with stirring. The present invention is a bactericidal agent in which a host compound is dissolved in an organic solvent such as methanol, and while stirring the solution, a solution in which a bactericidal guest compound is separately poured little by little to precipitate a bactericidal inclusion compound. Provided is a method for producing a fine bactericide clathrate compound crystal in a high yield, with good reproducibility, and in a stable manner, in the method for producing an inclusion compound. In the method of the present invention, a seed crystal of the clathrate compound prepared in advance is added in the middle of the step of pouring the solution in which the bactericidal guest compound is dissolved little by little.

【0006】すなわち、本発明の請求項1記載の包接化
合物の製造方法は、殺菌剤を包接することができるホス
ト化合物を溶解した溶液に殺菌剤を溶解した溶液を攪拌
下に注加して析出させ、殺菌剤包接化合物を製造する方
法において、前記殺菌剤として5−クロロ−2−メチル
−4−イソチアゾリン−3−オンを使用し、該5−クロ
ロ−2−メチル−4−イソチアゾリン−3−オンの溶液
を注加中のホスト化合物溶液に、予め調整した5−クロ
ロ−2−メチル−4−イソチアゾリン−3−オン包接化
合物の種結晶を添加することにより、微小粒径の5−ク
ロロ−2−メチル−4−イソチアゾリン−3−オン包接
化合物の析出を製造する方法である。
That is, the inclusion according to claim 1 of the present invention
The method for producing a compound is a method for producing a bactericide inclusion compound by pouring and depositing a solution in which a sterilizer is dissolved in a solution in which a sterilizer is included in a solution in which a bactericide can be clathrated under stirring. 5-chloro-2-methyl as the bactericide
-4-isothiazolin-3-one was used to
A solution of 2-methyl-4-isothiazolin-3-one was added to the solution of the host compound that was being added to the solution of 5-chloro
By adding a seed crystal of the inclusion compound of 2--2-methyl-4-isothiazolin-3-one , 5-
Inclusion of loro-2-methyl-4-isothiazolin-3-one
It is a method for producing precipitation of a compound.

【0007】また、請求項2記載の包接化合物の製造方
法は、前記請求項1において、前記ホスト化合物がビス
フェノール系化合物、フェノール系化合物、デオキシコ
ール酸、ジカルボン酸、又は芳香族カルボン酸である方
法である。
A method for producing an inclusion compound according to claim 2
The method according to claim 1, wherein the host compound is bis
Phenolic compounds, phenolic compounds, deoxyco
Acid, dicarboxylic acid, or aromatic carboxylic acid
Is the law.

【0008】請求項3記載の包接化合物の製造方法は、
前記種結晶の粒径が1〜300μmである方法である。
The method for producing an inclusion compound according to claim 3 is
In this method, the grain size of the seed crystal is 1 to 300 μm.

【0009】さらに、請求項4記載の包接化合物の製造
方法は、前記請求項1乃至3のいずれか1項において、
前記種結晶を析出する包接化合物に対して0.1〜10
00mg/Kg添加する方法である。
Furthermore, the production of an inclusion compound according to claim 4
The method according to any one of claims 1 to 3,
0.1-10 with respect to the inclusion compound that precipitates the seed crystal
This is a method of adding 00 mg / Kg.

【0010】本発明の方法において用いられる殺菌剤化
合物は、適当なホスト化合物によって包接化合物を形成
し得るものであり、効果的な水溶性殺菌剤として広く知
られている、下記
The bactericidal compound used in the method of the present invention is capable of forming an inclusion compound with a suitable host compound, and is widely known as an effective water-soluble bactericidal compound.

【0011】[0011]

【化1】 [Chemical 1]

【0012】で示される、5−クロロ−2−メチル−4
−イソチアゾリン−3−オン(以下Cl−MITと略称
する)を用いる。この水溶性殺菌剤は1〜50重量%、
好ましくは10〜20重量%の水溶液として用いる。
5-chloro-2-methyl-4 represented by
-Isothiazolin-3-one (hereinafter abbreviated as Cl-MIT) is used. This water-soluble germicide is 1 to 50% by weight,
It is preferably used as an aqueous solution of 10 to 20% by weight.

【0013】また本発明の方法において用いられるホス
ト化合物は、殺菌剤であるCl−MITと包接化合物を
形成するものであればよく、特に制限はないが、次のよ
うな化合物が挙げられる。 1)ビスフエノール系化合物
The host compound used in the method of the present invention is not particularly limited as long as it forms an inclusion compound with Cl-MIT which is a bactericidal agent , and the following compounds can be mentioned. 1) Bisphenol compounds

【0014】[0014]

【化2】 [Chemical 2]

【0015】式中Rは炭素数1〜4のアルキレン基また
はアルキリデン基を、Xは水素またはハロゲン原子を、
示す。具体例としては4,4′−エチリデンビスフエノ
ール、2,4′−イソプロピリデンビスフエノール、4,
4′−イソプロピリデンビスフエノール、2,2′−メ
チレンビス(4ークロロフエノール)等が挙げられる。 2)フエノール系化合物
In the formula, R is an alkylene group or alkylidene group having 1 to 4 carbon atoms, X is a hydrogen atom or a halogen atom,
Show. Specific examples include 4,4'-ethylidene bisphenol, 2,4'-isopropylidene bisphenol, 4,
4'-isopropylidene bisphenol, 2,2'-methylene bis (4-chlorophenol) and the like can be mentioned. 2) phenol compounds

【0016】[0016]

【化3】 [Chemical 3]

【0017】式中R1、R2はそれぞれ炭素数1〜4のア
ルキル基を示す。具体例としては2,4−ジ−t−ブチ
ルフエノール、2,4−ジ−プロピルフエノール、2−
プロピル−4−t−ブチルフエノールが挙げられる。 3)デオキシコール酸4)ジカルボン酸
In the formula, R1 and R2 each represent an alkyl group having 1 to 4 carbon atoms. Specific examples include 2,4-di-t-butylphenol, 2,4-di-propylphenol and 2-
Propyl-4-t-butylphenol may be mentioned. 3) Deoxycholic acid 4) Dicarboxylic acid

【0018】[0018]

【化4】 [Chemical 4]

【0019】式中R3は単結合または炭素数1〜4のア
ルキレン基、アルケニレン基またはアルキニレン基を示
す。具体例としてはシユウ酸、マロン酸、コハク酸、グ
ルタル酸、フマル酸、マレイン酸、アセチレンジカルボ
ン酸等が挙げられる。 5)芳香族カルボン酸
In the formula, R3 represents a single bond or an alkylene group having 1 to 4 carbon atoms, an alkenylene group or an alkynylene group. Specific examples include oxalic acid, malonic acid, succinic acid, glutaric acid, fumaric acid, maleic acid and acetylenedicarboxylic acid. 5) Aromatic carboxylic acid

【0020】[0020]

【化5】 [Chemical 5]

【0021】式中R4、R5、R6はそれぞれ独立して、
水素、ハロゲン、カルボキシル基、水酸基、ニトロ基、
アミノ基、カルボン酸無水物、あるいは炭素数1〜4の
アルキル基、アルケニル基、アルキニル基、アルコキシ
基、アルカノン基、またはアルカナール基を示す。具体
例としては安息香酸、4−クロロ安息香酸、2,4−ジ
クロロ安息香酸、2,4−ジブロモ安息香酸、2,4,6
−トリブロモ安息香酸、4−ヨード安息香酸、2,4−
ジヨード安息香酸、2,4,6−トリヨード安息香酸、
3,5−ジヨードサリチル酸、4−クロロ−3−ニトロ
安息香酸、2−クロロ−4−ニトロ安息香酸、4−クロ
ロ−2−ニトロ安息香酸、4−クロロ−2−ニトロ安息
香酸、フタル酸、イソフタル酸、テレフタル酸、トリメ
リット酸、ピロメリット酸、4−ニトロ−安息香酸、
2,4−ジニトロ安息香酸、4−ニトロフタル酸、3,5
−ジニトロサリチル酸、2−アミノ安息香酸、無水トリ
メリット酸、ゲンチシン酸(2,5−ジヒドロキシ安息
香酸)、プロトカテキュ酸(3,4−ジヒドロキシ安息
香酸)、サリチル酸、2,4,6−トリヒドロキシ安息香
酸、4−メチル安息香酸、4−メトキシ安息香酸、4−
カルボキシベンズアミド、4−ビニル安息香酸、4−エ
チニル安息香酸、4−アセチル安息香酸、4−カルボキ
シベンズアルデヒド等が挙げられる。これらのホスト化
合物はメタノール、エタノール、アセトン等の水溶性溶
媒を用い、通常10〜70重量%溶液として使用する
が、最適溶媒とその濃度は予備実験により決定する。ま
たホスト化合物溶液に対する殺菌剤溶液の注加量は0.
2〜5(重量比)が適当である。
In the formula, R4, R5 and R6 are each independently
Hydrogen, halogen, carboxyl group, hydroxyl group, nitro group,
An amino group, a carboxylic acid anhydride, or an alkyl group having 1 to 4 carbon atoms, an alkenyl group, an alkynyl group, an alkoxy group, an alkanone group, or an alkanal group is shown. Specific examples include benzoic acid, 4-chlorobenzoic acid, 2,4-dichlorobenzoic acid, 2,4-dibromobenzoic acid and 2,4,6.
-Tribromobenzoic acid, 4-iodobenzoic acid, 2,4-
Diiodobenzoic acid, 2,4,6-triiodobenzoic acid,
3,5-diiodosalicylic acid, 4-chloro-3-nitrobenzoic acid, 2-chloro-4-nitrobenzoic acid, 4-chloro-2-nitrobenzoic acid, 4-chloro-2-nitrobenzoic acid, phthalic acid , Isophthalic acid, terephthalic acid, trimellitic acid, pyromellitic acid, 4-nitro-benzoic acid,
2,4-dinitrobenzoic acid, 4-nitrophthalic acid, 3,5
-Dinitrosalicylic acid, 2-aminobenzoic acid, trimellitic anhydride, gentisic acid (2,5-dihydroxybenzoic acid), protocatechuic acid (3,4-dihydroxybenzoic acid), salicylic acid, 2,4,6-trihydroxybenzoic acid Acid, 4-methylbenzoic acid, 4-methoxybenzoic acid, 4-
Carboxybenzamide, 4-vinylbenzoic acid, 4-ethynylbenzoic acid, 4-acetylbenzoic acid, 4-carboxybenzaldehyde and the like can be mentioned. These host compounds use a water-soluble solvent such as methanol, ethanol or acetone, and are usually used as a 10 to 70% by weight solution. The optimum solvent and its concentration are determined by preliminary experiments. The amount of bactericide solution added to the host compound solution is 0.
2-5 (weight ratio) is suitable.

【0022】本発明で用いられる種結晶は、今から製造
する殺菌剤包接化合物と同一の、予め製造した殺菌剤包
接化合物の結晶で、粒径を1〜300μm、好ましくは
10〜150μmに調整したものを使用する。調整方法
としては乳鉢等で粉砕後篩い分ければよい。この種結晶
を、析出する包接化合物に対して0.1〜1000mg/
Kg、好ましくは1〜100mg/Kgの割合になるよ
うに、包接化合物を析出させる溶液をよく攪拌しなが
ら、添加する。種結晶を添加する時期は、ホスト溶液の
種類と濃度、殺菌剤溶液の種類と濃度等によって異なる
ので予め種結晶を使って予備試験を室温で行って定める
が、一般的には殺菌剤溶液を注加し混合溶液中に包接化
合物が過飽和となった時点が目安になる。実際上は殺菌
剤溶液を1/3程度注加した時点を目安にすればよい。
殺菌剤溶液の注加が終了した後も攪拌を1時間〜1日継
続し、結晶を十分に析出させる。その後真空濾過機、遠
心濾過機、加圧濾過機等により固液分離し、脱塩水で洗
浄して製品とする。
The seed crystal used in the present invention is a crystal of a preliminarily prepared fungicide inclusion compound which is the same as the fungicide inclusion compound to be manufactured now, and has a particle size of 1 to 300 μm, preferably 10 to 150 μm. Use the adjusted one. As an adjusting method, it may be pulverized in a mortar or the like and then sieved. This seed crystal was used in an amount of 0.1 to 1000 mg /
The solution for precipitating the clathrate compound is added while thoroughly stirring so that the concentration of Kg, preferably 1 to 100 mg / Kg. The timing of adding the seed crystal depends on the type and concentration of the host solution, the type and concentration of the bactericide solution, etc., so a preliminary test is performed in advance at room temperature using the seed crystal, but generally the sterilizer solution is used. The time when the inclusion compound becomes supersaturated in the mixed solution after pouring is a guide. Practically, the time when the bactericide solution is added about 1/3 may be used as a guide.
Even after the pouring of the bactericide solution is completed, stirring is continued for 1 hour to 1 day to sufficiently precipitate crystals. After that, solid-liquid separation is performed with a vacuum filter, a centrifugal filter, a pressure filter, or the like, and the product is washed with demineralized water.

【0023】[0023]

【実施例】(参考例) 1Lセパラブルフラスコにメタノール75gとホスト化
合物、4、4´−エチリデンビスフエノール(Lot
No.1)50gを加えて、半月板攪拌羽根(長さ5c
m)で攪拌してホスト化合物を完全に溶解した。セパラ
ブルフラスコを20°C恒温槽中に保ち、内容物を回転
速度500rpmで攪拌しながら、殺菌剤ケーソンWT
(登録商標、ロームアンドハース社製。Cl−MITを
10〜12重量%含む水溶液)300gを30分かけて
連続注加した。包接化合物の析出はケーソンWTの注加
開始9分後に始まった。注加終了後も攪拌を1時間継続
して、包接化合物を充分に析出させた。得られた包接化
合物は79.8gで、殺菌剤/ホストのモル比は1/1、
粒度は粒径300μm以下が95%以上であった。
EXAMPLES (Reference Example) 75 g of methanol and a host compound, 4,4′-ethylidene bisphenol (Lot) were placed in a 1 L separable flask.
No. 1) 50g was added, and the meniscus stirring blade (length 5c
The host compound was completely dissolved by stirring in m). Keep the separable flask in a constant temperature bath at 20 ° C and stir the contents at a rotation speed of 500 rpm while sterilizing caisson WT.
(Registered trademark, manufactured by Rohm and Haas. An aqueous solution containing 10 to 12% by weight of Cl-MIT) 300 g was continuously added over 30 minutes. Precipitation of the clathrate compound started 9 minutes after the start of pouring Caisson WT. After completion of the pouring, stirring was continued for 1 hour to sufficiently deposit the inclusion compound. The obtained clathrate was 79.8 g, and the bactericide / host molar ratio was 1/1,
The particle size was 95% or more when the particle size was 300 μm or less.

【0024】(比較例1) 上記(参考例)と同様に操作した。ただし、4、4´−
エチリデンビスフエノールは(参考例)の場合と異なる
ロット(Lot No.2)のものを用いた。包接化合物
の析出開始時間が参考例と異なり、ケーソンWTの注加
開始10分後であった。このように、4、4´−エチリ
デンビスフエノールのロットが異なると、包接化合物の
析出開始時間が異なることがあることが分かった。
Comparative Example 1 The same operation as in the above (Reference Example) was performed. However, 4, 4'-
The ethylidene bisphenol used was a lot (Lot No. 2) different from that of (Reference Example). The deposition start time of the clathrate was different from that of the reference example, and was 10 minutes after the start of caisson WT injection. As described above, it was found that when the lots of 4,4′-ethylidene bisphenol were different, the initiation time of precipitation of the clathrate compound was sometimes different.

【0025】(比較例2) 上記(参考例)と同様に、4、4´−エチリデンビスフ
エノール(Lot No.1)を用いて、ただし恒温槽温
度を10°Cに下げて操作した。包接化合物の結晶は、
ケーソンWTの注加終了後攪拌を1時間継続しても析出
しなかった。そこで攪拌を止めてフラスコ内部の溶液を
取りだそうとしたところ、結晶が急激に析出した。この
結晶は粒子が相互に凝固し全体が塊となり、フラスコ内
壁に固着して取り出しが困難であった。しかし、この結
晶でも、殺菌剤/ホストモル比が(比較例1)と同じ1/
1の、包接化合物であった。このように、この包接化合
物を10°Cで製造すると、結晶の析出開始時期の予測
が困難であり、また微小結晶が得られないことが分かっ
た。
Comparative Example 2 In the same manner as in the above (Reference Example), 4,4′-ethylidene bisphenol (Lot No. 1) was used, but the temperature of the constant temperature bath was lowered to 10 ° C. for operation. The inclusion compound crystals are
After completion of pouring Caisson WT, precipitation did not occur even if stirring was continued for 1 hour. Then, when the stirring was stopped and the solution in the flask was tried to be taken out, crystals rapidly precipitated. Particles of this crystal were mutually solidified to form a lump as a whole, which was fixed to the inner wall of the flask and was difficult to take out. However, even with this crystal, the sterilizing agent / host molar ratio was the same as (Comparative Example 1) 1 /.
It was an inclusion compound of 1. As described above, it was found that when this clathrate compound was produced at 10 ° C., it was difficult to predict the time to start the precipitation of crystals, and fine crystals could not be obtained.

【0026】(実施例1) 上記(比較例2)と同様に、4、4´−エチリデンビス
フエノール(LotNo.2)を用いて操作した。ただ
し、ケーソンWT注加開始9分後に4,4´−エチリデ
ンビスフェノール/Cl−MITの種結晶(粒径150
μm以下)1mgを添加した。この種結晶の添加と同時
に、包接化合物の析出が始まった。このように、種結晶
を用いることによって析出開始時間を制御できることが
わかった。
(Example 1) In the same manner as in (Comparative Example 2 ) above, operation was performed using 4,4'-ethylidene bisphenol (Lot No. 2). However, seed crystals of 4,4'-ethylidene bisphenol / Cl-MIT (particle size 150
1 μm or less) was added. Simultaneously with the addition of this seed crystal, precipitation of the clathrate compound started. As described above, it was found that the seed start time can be controlled by using the seed crystal.

【0027】(実施例2) 上記(比較例2)と同様に操作した。ただし、ケーソン
WT注加開始10分後に、4,4´−エチリデンビスフ
ェノール/Cl−MIT包接化合物の種結晶(粒径15
0μm以下)1mgを添加した。この種結晶の添加と同
時に包接化合物の析出が始まった。包接化合物の収量は
80.1g、殺菌剤/ホストのモル比は1/1、結晶粒度
は粒径300μm以下が95%以上であった。以上の比
較例と実施例を対比することにより、種結晶を添加する
ことにより、包接化合物の析出時期が制御でき、低温の
析出し難い条件下でも析出させることができ、しかも微
小な結晶が得られることがわかる。
Example 2 The same operation as in (Comparative Example 2) was performed. However, 10 minutes after the start of the caisson WT injection, seed crystals of 4,4'-ethylidene bisphenol / Cl-MIT inclusion compound (particle size 15
1 μm) was added. Simultaneously with the addition of this seed crystal, precipitation of the clathrate compound started. The inclusion compound yield was 80.1 g, the fungicide / host molar ratio was 1/1, and the crystal grain size was 95% or more when the particle size was 300 μm or less. By comparing the above Comparative Examples and Examples, by adding a seed crystal, it is possible to control the precipitation time of the clathrate compound, and it is possible to precipitate even under conditions where precipitation at low temperature is difficult, and a minute crystal You can see that you can get it.

【0028】[0028]

【発明の効果】本発明によれば、冬季の低温条件下等、
包接化合物の結晶が析出し難い条件下でも、析出を開始
させることができる。また本発明を実施することによ
り、析出する結晶の粗大化が抑制され、微小結晶が再現
性良く高収率で得られる。従って包接化合物の製造工程
が合理化できる。
According to the present invention, in low temperature conditions in winter,
Precipitation can be initiated even under conditions in which the inclusion compound crystals are unlikely to precipitate. Further, by carrying out the present invention, coarsening of precipitated crystals is suppressed, and fine crystals are obtained with good reproducibility and high yield. Therefore, the manufacturing process of the inclusion compound can be rationalized.

【0029】[0029]

フロントページの続き (56)参考文献 特開 平5−163104(JP,A) 特開 平2−164835(JP,A) 特開 平3−178906(JP,A) 特開 平2−178243(JP,A) 特開 平5−85954(JP,A) 特開 平5−32570(JP,A) 特開 平7−33755(JP,A) 特開 平4−283528(JP,A) 特開 昭63−175068(JP,A) 北村光孝,異性体混合系での包接化合 物の分子認識と多形析出,化学工学会秋 季大会研究発表講演要旨集,日本,1992 年,Vol.25th,No.Pt1,p p.355 北村光孝,晶析操作における多形制 御,分離技術,1994年11月25日,第24 巻,第6号,第365−369頁 中川寛,難溶性薬物の製剤化,JJS HP;1988年,VoL.24,No.11, pp.1175−1182 (58)調査した分野(Int.Cl.7,DB名) A01N 43/80 A01N 25/22 C07D 275/02 CA(STN) REGISTRY(STN)Continuation of front page (56) Reference JP-A-5-163104 (JP, A) JP-A-2-164835 (JP, A) JP-A-3-178906 (JP, A) JP-A-2-178243 (JP , A) JP 5-85954 (JP, A) JP 5-32570 (JP, A) JP 7-33755 (JP, A) JP 4-283528 (JP, A) JP 63-175068 (JP, A) Mitsutaka Kitamura, Molecular Recognition and Polymorphic Precipitation of Inclusion Compounds in Mixed Isomers, Proceedings of the Autumn Meeting of the Chemical Society of Japan, Japan, 1992, Vol. 25th, No. Pt1, pp. 355 Mitsutaka Kitamura, Polymorphism Control in Crystallization Operation, Separation Technology, November 25, 1994, Volume 24, No. 6, pages 365-369 Hiroshi Nakagawa, Formulation of poorly soluble drugs, JJS HP; 1988 , VoL. 24, No. 11, pp. 1175-1182 (58) Fields surveyed (Int.Cl. 7 , DB name) A01N 43/80 A01N 25/22 C07D 275/02 CA (STN) REGISTRY (STN)

Claims (4)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 殺菌剤を包接することができるホスト化
合物を溶解した溶液に殺菌剤を溶解した溶液を攪拌下に
注加して析出させ、殺菌剤包接化合物を製造する方法に
おいて、前記殺菌剤として5−クロロ−2−メチル−4
−イソチアゾリン−3−オンを使用し、該5−クロロ−
2−メチル−4−イソチアゾリン−3−オンの溶液を注
加中のホスト化合物溶液に、予め調整した5−クロロ−
2−メチル−4−イソチアゾリン−3−オン包接化合物
の種結晶を添加することにより、微小粒径の5−クロロ
−2−メチル−4−イソチアゾリン−3−オン包接化合
物を製造することを特徴とする包接化合物の製造方法。
1. A method for producing a disinfectant inclusion compound by pouring a solution in which a disinfectant is dissolved into a solution in which a host compound capable of encapsulating a disinfectant is dissolved under stirring to prepare a disinfectant inclusion compound, 5-chloro-2-methyl-4 as an agent
-Isothiazolin-3-one using the 5-chloro-
A solution of 2-methyl-4-isothiazolin-3-one was added to the solution of the host compound that was being added to the pre-conditioned 5-chloro-
By adding a seed crystal of the 2-methyl-4-isothiazolin-3-one inclusion compound , 5-chloro-5
2-Methyl-4-isothiazolin-3-one inclusion compound
A method for producing an inclusion compound, comprising producing a product.
【請求項2】 前記ホスト化合物がビスフェノール系化
合物、フェノール系化合物、デオキシコール酸、ジカル
ボン酸、又は芳香族カルボン酸であることを特徴とする
請求項1記載の包接化合物の製造方法。
2. The host compound is bisphenol-based
Compound, phenolic compound, deoxycholic acid, dicar
Characterized by being a boric acid or an aromatic carboxylic acid
The method for producing an inclusion compound according to claim 1.
【請求項3】 前記種結晶の粒径が1〜300μmであ
ることを特徴とする請求項1又は2記載の包接化合物の
製造方法。
3. The grain size of the seed crystal is 1 to 300 μm.
The inclusion compound according to claim 1 or 2, characterized in that
Production method.
【請求項4】 前記種結晶を析出する包接化合物に対し
て0.1〜1000mg/Kg添加することを特徴とす
る請求項1乃至3のいずれか1項記載の包接化合物の製
造方法。
4. An inclusion compound for precipitating the seed crystal
Characterized by adding 0.1 to 1000 mg / Kg
A process for producing an inclusion compound according to any one of claims 1 to 3.
Build method.
JP24874494A 1994-09-16 1994-09-16 Method for producing fungicide inclusion compound Expired - Fee Related JP3417085B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP24874494A JP3417085B2 (en) 1994-09-16 1994-09-16 Method for producing fungicide inclusion compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24874494A JP3417085B2 (en) 1994-09-16 1994-09-16 Method for producing fungicide inclusion compound

Publications (2)

Publication Number Publication Date
JPH0892015A JPH0892015A (en) 1996-04-09
JP3417085B2 true JP3417085B2 (en) 2003-06-16

Family

ID=17182725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24874494A Expired - Fee Related JP3417085B2 (en) 1994-09-16 1994-09-16 Method for producing fungicide inclusion compound

Country Status (1)

Country Link
JP (1) JP3417085B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011376834A1 (en) * 2011-09-16 2014-02-13 Evonik Rohm Gmbh Preparation of methacrylic acid

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
中川寛,難溶性薬物の製剤化,JJSHP;1988年,VoL.24,No.11,pp.1175−1182
北村光孝,晶析操作における多形制御,分離技術,1994年11月25日,第24巻,第6号,第365−369頁
北村光孝,異性体混合系での包接化合物の分子認識と多形析出,化学工学会秋季大会研究発表講演要旨集,日本,1992年,Vol.25th,No.Pt1,pp.355

Also Published As

Publication number Publication date
JPH0892015A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
JP5295190B2 (en) Method for crystallization of reverse transcriptase inhibitor using reverse solvent
JPH0558411B2 (en)
US6462227B2 (en) Stabilized o-iodoxybenzoic acid compositions and process for the preparation thereof
JP3417085B2 (en) Method for producing fungicide inclusion compound
EP1086067B1 (en) Method for producing alkali metal alcoholates
EP0417003A2 (en) Use of antiprogestomimetics for stimulating ovulation
FR2504918A1 (en) PROCESS FOR THE PREPARATION OF D-2- (6-METHOXY-2-NAPHTHYL) -PROPIONIC ACID
US4189596A (en) Preparing 2-arylalkanoic acid derivatives
EP0558621B1 (en) Process for improving flow characteristics of crystalline ibuprofen
EP0703915B1 (en) Xamoneline tartrate
JP3266395B2 (en) Crystallization method of organic chemicals
US6677453B1 (en) Production of polymorphic forms I and II of finasteride by complexation with group I or II metal salts
JPS5810544A (en) Preparation of optical active p-hydroxyphenyl glycine salt
JP2003502422A (en) Preparation of paroxetine and structurally related compounds
JP2002517511A (en) Process for producing and purifying organic salts of aspartame
JP3644998B2 (en) Method for selectively obtaining crystals of benzylidene derivatives
JP3208971B2 (en) Process for producing O, O'-diacyltartaric acid
JPH08183744A (en) Production of inclusion compound
JP2016505569A (en) Method for making an active crystalline material
JP2002531454A (en) Process for preparing paroxetine hydrochloride propan-2-ol solvate
JPH06506223A (en) Method for producing 2-alkyl-4-acyl-6-tert-butylphenol compound
JPH07330520A (en) Molecular compound of germicide
TWI314556B (en) Process and novel intermediates for preparing fulvestrant
EP0950050A1 (en) Method for the crystallisation of a tetrahydopyridin derivative and resulting crystalline forms
JP2852393B2 (en) Method for producing phenylpropionic acid derivative

Legal Events

Date Code Title Description
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080411

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080411

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090411

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090411

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100411

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100411

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110411

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120411

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130411

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140411

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees